ROLE OF INTERLEUKIN-1 RECEPTOR ANTAGONIST IN INFLAMMATORY BOWEL-DISEASE (IBD)

被引：0
|
作者：
MITSUYAMA, K [1 ]
TOYONAGA, A [1 ]
SASAKI, E [1 ]
NISHIYAMA, T [1 ]
TSURUTA, O [1 ]
HARADA, K [1 ]
TORIMURA, T [1 ]
TANIKAWA, K [1 ]
机构：
[1] KURUME UNIV,SCH MED,DEPT MED 2,KURUME,FUKUOKA 830,JAPAN
来源：
GASTROENTEROLOGY | 1993年 / 104卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A747 / A747
页数：1
相关论文
共 50 条
  • [1] COLONIC MUCOSAL INTERLEUKIN-1 RECEPTOR ANTAGONIST IN INFLAMMATORY BOWEL-DISEASE
    NISHIYAMA, T
    MITSUYAMA, K
    TOYONAGA, A
    SASAKI, E
    TANIKAWA, K
    DIGESTION, 1994, 55 (06) : 368 - 373
  • [2] RELATIONSHIP OF INTERLEUKIN-1 RECEPTOR ANTAGONIST TO MUCOSAL INFLAMMATION IN INFLAMMATORY BOWEL-DISEASE
    HYAMS, JS
    FITZGERALD, JE
    WYZGA, N
    MULLER, R
    TREEM, WR
    JUSTINICH, CJ
    KREUTZER, DL
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1995, 21 (04): : 419 - 425
  • [3] Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease
    Cominelli, F
    Pizarro, TT
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 : 49 - 53
  • [4] CHARACTERIZATION OF CIRCULATING INTERLEUKIN-1 RECEPTOR ANTAGONIST EXPRESSION IN CHILDREN WITH INFLAMMATORY BOWEL-DISEASE
    HYAMS, JS
    FITZGERALD, JE
    WYZGA, N
    TREEM, WR
    JUSTINICH, CJ
    KREUTZER, DL
    DIGESTIVE DISEASES AND SCIENCES, 1994, 39 (09) : 1893 - 1899
  • [5] Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease - Discussion
    Mahida, Y
    Cominelli, F
    Jewell, DP
    Elson, CO
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 : 54 - 54
  • [6] Mucosal imbalance of interleukin-1β and interleukin-1 receptor antagonist in canine inflammatory bowel disease
    Maeda, Shingo
    Ohno, Koichi
    Nakamura, Kenji
    Uchida, Kazuyuki
    Nakashima, Ko
    Fukushima, Kenjiro
    Tsukamoto, Atsushi
    Goto-Koshino, Yuko
    Fujino, Yasuhito
    Tsujimoto, Hajime
    VETERINARY JOURNAL, 2012, 194 (01): : 66 - 70
  • [7] ROLE OF INTERLEUKIN-1 IN INFLAMMATORY BOWEL-DISEASE - ENHANCED PRODUCTION DURING ACTIVE DISEASE
    LIGUMSKY, M
    SIMON, PL
    KARMELI, F
    RACHMILEWITZ, D
    GUT, 1990, 31 (06) : 686 - 689
  • [8] Interleukin-1 receptor antagonist VNTR-polymorphism in inflammatory bowel disease
    Vijgen, L
    Van Gysel, M
    Rector, A
    Thoelen, I
    Esters, N
    Ceelen, T
    Vangoidsenhoven, E
    Vermeire, S
    Rutgeerts, P
    Van Ranst, M
    GENES AND IMMUNITY, 2002, 3 (07) : 400 - 406
  • [9] Interleukin-1 receptor antagonist VNTR-polymorphism in inflammatory bowel disease
    L Vijgen
    M Van Gysel
    A Rector
    I Thoelen
    N Esters
    T Ceelen
    E Vangoidsenhoven
    S Vermeire
    P Rutgeerts
    M Van Ranst
    Genes & Immunity, 2002, 3 : 400 - 406
  • [10] AN INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL-1RA) GENE-THERAPY MODEL FOR THE TREATMENT OF INFLAMMATORY BOWEL-DISEASE
    PIZARRO, TT
    NG, RY
    MONSACCHI, L
    COMINELLI, F
    GASTROENTEROLOGY, 1994, 106 (04) : A754 - A754
12345